RBM20 and cardiomyopathy: Transgenic overexpression of CaMKIIδA alone is sufficient to induce a phenotype similar to RBM20 cardiomyopathy, and strikingly this largely affects male mice, leading to ~ 50% lethality at 8 weeks of age, while females are unaffected [16].